Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims

Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus

(2016) Yong Li et al.   HIPPOCAMPUS

FGFR1–5-HT1A Heteroreceptor Complexes: Implications for Understanding and Treating Major Depression

(2016) Dasiel O. Borroto-Escuela et al.   TRENDS IN NEUROSCIENCES

Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats

(2015) Abbasali Rahimi et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Cannabidiol as a Potential Treatment for Anxiety Disorders

(2015) Esther M. Blessing et al.   Neurotherapeutics

The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects

(2014) Amaia M. Erdozain et al.   ADDICTION BIOLOGY

Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism

(2014) Salvador Sierra et al.   Brain Structure & Function

Editorial (Thematic Issue: Understanding the Role of Heteroreceptor Complexes in the Central Nervous System)

(2014) Kjell Fuxe et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

(2014) Orrin Devinsky et al.   EPILEPSIA

CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum

(2014) E. Martínez-Pinilla et al.   EXPERIMENTAL NEUROLOGY

An overview of the neurobiology of suicidal behaviors as one meta-system

(2014) M Sokolowski et al.   MOLECULAR PSYCHIATRY

The molecular bases of the suicidal brain

(2014) Gustavo Turecki   NATURE REVIEWS NEUROSCIENCE

Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors

(2013) María S. García-Gutiérrez et al.   NEUROPHARMACOLOGY

Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment

(2013) Marina Mitjans et al.   PSYCHOPHARMACOLOGY

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

(2012) A. C. Campos et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

The L- -Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity

(2011) J. M. Moreno-Navarrete et al.   DIABETES

The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats

(2011) A. Díaz-Arteaga et al.   DIABETES OBESITY & METABOLISM

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans

(2011) Silvana Y Romero-Zerbo et al.   JOURNAL OF ENDOCRINOLOGY

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

(2011) Li Huang et al.   LABORATORY INVESTIGATION

Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice

(2011) Antonio Ortega-Alvaro et al.   NEUROPSYCHOPHARMACOLOGY

The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55

(2011) Niklas Schuelert et al.   NEUROSCIENCE LETTERS

Measurable impact of RNA quality on gene expression results from quantitative PCR

(2011) Joëlle Vermeulen et al.   NUCLEIC ACIDS RESEARCH

A role for L-α-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells

(2010) Lesley A Ford et al.   BRITISH JOURNAL OF PHARMACOLOGY

Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors

(2010) MS García-Gutiérrez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice

(2010) María S García-Gutiérrez et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation

(2010) R Piñeiro et al.   ONCOGENE

Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression

(2010) Palmiero Monteleone et al.   PHARMACOLOGICAL RESEARCH

Characterization of QKI Gene Expression, Genetics, and Epigenetics in Suicide Victims with Major Depressive Disorder

(2009) Timothy A. Klempan et al.   BIOLOGICAL PSYCHIATRY

Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

(2009) Q.-R. Liu et al.   GENES BRAIN AND BEHAVIOR

Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment

(2009) Leyre Urigüen et al.   PSYCHOPHARMACOLOGY

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1knockout mice

(2008) Ester Aso et al.   JOURNAL OF NEUROCHEMISTRY

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

(2008) Penny C. Staton et al.   PAIN

Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

(2008) Emmanuel S. Onaivi et al.   PLoS One

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

The orphan receptor GPR55 is a novel cannabinoid receptor

(2007) E Ryberg et al.   BRITISH JOURNAL OF PHARMACOLOGY